Clinical Trials
4
Active:0
Completed:2
Trial Phases
3 Phases
Phase 1:1
Phase 2:1
Not Applicable:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Not Applicable
2 (50.0%)Phase 1
1 (25.0%)Phase 2
1 (25.0%)No trials found
News
Ivermectin Mass Treatment Reduces Malaria Transmission by 26% in Landmark BOHEMIA Trial
The BOHEMIA trial, the largest study on ivermectin for malaria to date, demonstrated a 26% reduction in new malaria infections when administered alongside standard bed nets in Kenya.
CEPI Backs Phase II Trial of Rift Valley Fever Vaccine in Kenya
CEPI is funding Phase II clinical trials in Kenya for the ChAdOx1 RVF vaccine against Rift Valley fever, following promising Phase I results.